The purpose of this clinical trial was to compare the severity of acute brain injury in neonates affected by HIE and treated with EPO vs. placebo by means of conventional MRI supported by diffusion-weighted imaging (DWI) and evaluating the correlation between volume of acute brain injury and outcome at 12 months of age. This evidence concerns the gene EPO and perinatal asphyxia.